Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

QUALCOMM, Inc. (QCOM) – Intel Corporation (INTC)’s Quark Quandary: Can Something so Small Fuel Big Growth?

Page 1 of 2

It’s no secret that Intel Corporation (NASDAQ:INTC) has missed out on the explosive growth in mobile computing. It’s also no secret that declining PC sales are weighing heavily on the company’s future prospects. However, Intel Corporation (NASDAQ:INTC)’s just-announced Quark microprocessors are its first serious foray into the tiny system on a chip, or SoCs, that are being found in progressively more and more of the things we use.

Can Intel Corporation (NASDAQ:INTC) become “all microprocessors for all things,” or is this a step into a price-driven, commodity business that will take focus away from more profitable segments like mobile? Let’s take a look.

Intel Corporation (NASDAQ:INTC)

Internet of things
The world around us is becoming more connected every day, almost to a pervasive extent as microprocessors and WiFi integrate more than just consumer electronics into our online lives. Everything from the Nest thermostat to to WiFi enabled refrigerators contain SoCs, enabling us to access them remotely, or use them in ways that we never imagined before. Industrial use of these small, integrated chips is growing like crazy, too.

To heck with wearable computing — what about swallowable computing?
The ability to shrink microprocessors to a size that can be embedded in an ingestible medicine isn’t that far removed from science fiction. Startup Proteus Digital Health has already developed sensors that can transmit a signal when they interact with bodily fluids in digestion, so in a few years, we could see more powerful ingestible systems that are able to measure, record, and report data about our bodies.

Freescale Semiconductor Ltd (NYSE:FSL) is already making chips that are small enough, with its Kinetis Micro-CPUs, or MCUs. At 2 millimeters by 2 millimeters at their smallest so far, the barrier between what’s theoretically possible and what’s real isn’t as wide as you may think. The question is multi-faceted, though, as to what the real benefits could be, and how large the potential market for this sort of technology will become. Add in concerns about patient privacy and swallowing a tiny computer that’s transmitting data about your health may not be appealing, no matter the potential benefits. Freescale Semiconductor Ltd (NYSE:FSL), quite frankly, should be concerned that Intel Corporation (NASDAQ:INTC) is moving into these smaller SoCs. The company’s business is based on purpose-built microprocessors in a variety of industries, including automotive and health care devices, and seeing Intel Corporation (NASDAQ:INTC) potentially step into parts of this segment is a serious threat.

QUALCOMM, Inc. (NASDAQ:QCOM) is also involved in the medical field with its QUALCOMM, Inc. (NASDAQ:QCOM) Life subsidiary, and the 2net Platform that’s targeted at connectivity for medical devices, specifically providing secure interoperability. However, QUALCOMM, Inc. (NASDAQ:QCOM)’s ARM-based Snapdragon processors make up a significant share of the still growing mobile market. The most recent quarter’s revenue and operating income growth of 35% and 31% were largely driven by the 22% growth in “MSM” shipments, which is QUALCOMM, Inc. (NASDAQ:QCOM)’s name for its mobile SoCs, specifically the Snapdragon series of mobile processors. Lastly, the company’s projections for the rest of the year make it clear that mobile is still the focus. QUALCOMM, Inc. (NASDAQ:QCOM)’s 21%-35% revenue growth corresponds to its projected growth in MSM shipments of 21%-28%.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!